Enveric Biosciences Shares Drop Premarket After $1.5M Equity Raising Prices

Dow Jones

Jan 28

By Robb M. Stewart

Enveric Biosciences's shares were down sharply ahead of the opening bell after the biotechnology company priced a roughly $1.5 million stock offering.

In premarket trading, the shares were 13% lower at $3.85. By Tuesday's close, the shares had risen 22% in the new year but were down 91% over the prior 12 months.

Enveric said Wednesday it entered into definitive agreements for sale of 328,802 of its shares at $4.41 each in a registered direct offering.

In a concurrent private placement, the company will issue unregistered series G warrants to purchase up to 328,802 shares of common stock and unregistered series H warrants to buy up to 328,802 shares. Both the series G and series H warrants will have an exercise price of $4.16 each.

The company said it plans to use the proceeds from the offering for product development, working capital and general corporate purposes.

Write to Robb M. Stewart at robb.stewart@wsj.com

(END) Dow Jones Newswires

January 28, 2026 08:31 ET (13:31 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2606062711"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2606062711\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2606062711?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-28 21:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2606062711","market":"sh","top_or_hot":-1,"title":"Enveric Biosciences Shares Drop Premarket After $1.5M Equity Raising Prices","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Robb M. Stewart \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/ENVB\">Enveric Biosciences</a>'s shares were down sharply ahead of the opening bell after the biotechnology company priced a roughly $1.5 million stock offering. \n</p>\n<p>\n  In premarket trading, the shares were 13% lower at $3.85. By Tuesday's close, the shares had risen 22% in the new year but were down 91% over the prior 12 months. \n</p>\n<p>\n  Enveric said Wednesday it entered into definitive agreements for sale of 328,802 of its shares at $4.41 each in a registered direct offering. \n</p>\n<p>\n  In a concurrent private placement, the company will issue unregistered series G warrants to purchase up to 328,802 shares of common stock and unregistered series H warrants to buy up to 328,802 shares. Both the series G and series H warrants will have an exercise price of $4.16 each. \n</p>\n<p>\n  The company said it plans to use the proceeds from the offering for product development, working capital and general corporate purposes. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 28, 2026 08:31 ET (13:31 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Enveric Biosciences Shares Drop Premarket After $1.5M Equity Raising Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEnveric Biosciences Shares Drop Premarket After $1.5M Equity Raising Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-28 21:31</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Robb M. Stewart \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/ENVB\">Enveric Biosciences</a>'s shares were down sharply ahead of the opening bell after the biotechnology company priced a roughly $1.5 million stock offering. \n</p>\n<p>\n  In premarket trading, the shares were 13% lower at $3.85. By Tuesday's close, the shares had risen 22% in the new year but were down 91% over the prior 12 months. \n</p>\n<p>\n  Enveric said Wednesday it entered into definitive agreements for sale of 328,802 of its shares at $4.41 each in a registered direct offering. \n</p>\n<p>\n  In a concurrent private placement, the company will issue unregistered series G warrants to purchase up to 328,802 shares of common stock and unregistered series H warrants to buy up to 328,802 shares. Both the series G and series H warrants will have an exercise price of $4.16 each. \n</p>\n<p>\n  The company said it plans to use the proceeds from the offering for product development, working capital and general corporate purposes. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 28, 2026 08:31 ET (13:31 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4215","symbol_name":"住宅房地产投资信托","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2606062711","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2606062711","pubTimestamp":1769607060,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Enveric Biosciences's shares were down sharply ahead of the opening bell after the biotechnology company priced a roughly $1.5 million stock offering.In premarket trading, the shares were 13% lower at $3.85. By Tuesday's close, the shares had risen 22% in the new year but were down 91% over the prior 12 months.Enveric said Wednesday it entered into definitive agreements for sale of 328,802 of its shares at $4.41 each in a registered direct offering.In a concurrent private placement, the company will issue unregistered series G warrants to purchase up to 328,802 shares of common stock and unregistered series H warrants to buy up to 328,802 shares. Both the series G and series H warrants will have an exercise price of $4.16 each.The company said it plans to use the proceeds from the offering for product development, working capital and general corporate purposes.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4215":"住宅房地产投资信托","BK4007":"制药","ENVB":"Enveric Biosciences","BK4588":"碎股","BK4585":"ETF&股票定投概念","EQR":"资产住宅公司"},"translate_title":"Enveric Biosciences股价在150万美元股权融资后盘前下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EQR":1.5,"ENVB":1.5},"content_text":"By Robb M. Stewart \n\n\n \n\n\nEnveric Biosciences's shares were down sharply ahead of the opening bell after the biotechnology company priced a roughly $1.5 million stock offering. \n\n\n  In premarket trading, the shares were 13% lower at $3.85. By Tuesday's close, the shares had risen 22% in the new year but were down 91% over the prior 12 months. \n\n\n  Enveric said Wednesday it entered into definitive agreements for sale of 328,802 of its shares at $4.41 each in a registered direct offering. \n\n\n  In a concurrent private placement, the company will issue unregistered series G warrants to purchase up to 328,802 shares of common stock and unregistered series H warrants to buy up to 328,802 shares. Both the series G and series H warrants will have an exercise price of $4.16 each. \n\n\n  The company said it plans to use the proceeds from the offering for product development, working capital and general corporate purposes. \n\n\n \n\n\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 28, 2026 08:31 ET (13:31 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}